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Since  Dr Sato  at Hiroshima  City  Hospital  ﬁrst  recognized  and reported  the  concept  of  tako-tsubo
cardiomyopathy  in  1990,  this  disorder  has  become  accepted  worldwide  as  a distinct  clinical  entity.  Tako-
tsubo  cardiomyopathy  is an  important  disorder  as  a differential  diagnosis  of  acute  myocardial  infarction.
This disorder  usually  occurs  in  postmenopausal  women  of  an  advanced  age,  and is characterized  by
transient  left  ventricular  apical  wall  motion  abnormalities  associated  with  emotional  or  physical  stress.ako-tsubo
tress
entricular dysfunction
pical ballooning
Typically,  left ventricular  apical  wall  motion  abnormalities  are  transient  and resolve  during  a  period
of days  to weeks.  The  prognosis  is generally  favorable.  However,  several  acute  complications  have  been
reported  such  as  congestive  heart  failure,  cardiac  rupture,  hypotension,  left  ventricular  apical  thrombosis,
or Torsade  de Pointes.  Several  possible  mechanisms  such  as  multivessel  coronary  artery  spasm,  coro-
nary microvascular  dysfunction,  myocarditis,  or  catecholamine  toxicity  have  been  proposed  to  explain
tako-tsubo  cardiomyopathy,  but  its  pathophysiology  is  not  well  understood.©  2012  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.
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ntroduction
A novel cardiac syndrome exhibiting transient left ventricu-
ar apical wall motion abnormalities associated with emotional or
hysical stress has become accepted worldwide as a distinct clin-
patients. More recently, this disorder has been called by various
names based on its most important inciting factor or its angiog-
raphic image: stress-related cardiomyopathy [5] or transient left
ventricular apical ballooning syndrome [6,7]. In 2006, the American
Heart Association incorporated this disorder into the classiﬁcationcal entity. This disorder has been widely called the tako-tsubo
ardiomyopathy [1–4]. Tako-tsubo is a pot with a round bottom
nd narrow neck used for trapping octopuses in Japan (Fig. 1),
hich resembles the left ventriculogram during systole in these
∗ Corresponding author at: 1-2-3, Kasumi-cho, Minami-ku, Hiroshima 734-8551,
apan. Tel.: +81 82 257 5540; fax: +81 82 257 1569.
E-mail address: skurisu@nifty.com (S. Kurisu).
914-5087/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.06.015of cardiomyopathies as an acquired cardiomyopathy [8].  In this
review, we  will summarize the current knowledge on tako-tsubo
cardiomyopathy including clinical features and potential patho-
physiological mechanisms.History of tako-tsubo cardiomyopathy
Even before 1990, several reports had shown acute and
reversible left ventricular apical wall motion abnormalities after
vier Ltd. All rights reserved.
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Fig. 2. Table of contents including the ﬁrst report of tako-tsubo cardiomyopathy
AFig. 1. Tako-tsubo.
motional or physical stress. In 1985, 6 cases of transient left
entricular apical wall motion abnormalities after non-cardiac
urgery were reported in Japan [9].  In these cases, coronary
ngiography was not performed. In 1986, a female case of tran-
ient left ventricular apical wall motion abnormalities after her
on’s suicide was reported in the USA [10]. In this case, coro-
ary angiography revealed no signiﬁcant stenosis. Similar cases
omplicated by pheochromocytoma or subarachnoid hemorrhage
ere also recognized about that time [11,12]. These reports sug-
ested several possible pathophysiological mechanisms to explain
his phenomenon including myocarditis, coronary artery spasm, or
ocal myocytolysis due to catecholamine surge.
Fig. 3. Left ventriculogram and electrocardiogram in tako-tsubo cardiomyop
dapted from Ref. [14], with permission.described by Dr Sato.
Adapted from Ref. [1],  with permission.
In 1990, Dr Sato at Hiroshima City Hospital ﬁrst recognized the
concept of reversible left ventricular apical wall motion abnormali-
ties without coronary artery disease (CAD), and originally proposed
the term “tako-tsubo-like left ventricular dysfunction” because the
shape of left ventriculogram during systole resembled a tako-tsubo
[1] (Fig. 2). In Japan, this disorder was gradually recognized through
the funny name and subsequent his colleagues’ reports [1–4].After 2000, Japanese researchers introduced this disorder out-
side Japan with English papers, and its concept and the name
“tako-tsubo cardiomyopathy” have been gradually recognized
athy (left panel) and anterior acute myocardial infarction (right panel).
 of Cardiology 60 (2012) 429–437 431
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Fig. 4. Tako-tsubo cardiomyopathy after upper gastrointestinal examination. Swal-S. Kurisu, Y. Kihara / Journal
orldwide [3,6,7,13].  The number of published reports of patients
ith tako-tsubo cardiomyopathy has been steadily increasing dur-
ng the past decade.
iagnosis
In tako-tsubo cardiomyopathy as well as acute myocardial
nfarction (AMI), most patients have chest symptoms, electro-
ardiographic (ECG) abnormalities or left ventricular apical wall
otion abnormalities during the early stage (Fig. 3) [14]. Throm-
olytic agents are useful for achieving early reperfusion in patients
ith AMI. However, inappropriate administration of thrombolytic
gents may  lead to harm in patients with tako-tsubo cardiomy-
pathy. Therefore, it is important to obtain an early and precise
iagnosis in these patients. It would be reasonable to per-
orm coronary angiography in patients with suspected tako-tsubo
ardiomyopathy during early phase if it is clinically possible. Tako-
subo cardiomyopathy has been diagnosed classically based on
ngiographic ﬁndings including left ventricular apical wall motion
bnormalities and the absence of obstructive CAD or acute plaque
upture. Researchers at Mayo Clinic proposed their criteria in 2004,
nd subsequently showed its modiﬁed version in 2008 as follows
15]: (1) transient hypokinesis, akinesis, or dyskinesis of the left
entricular mid  segments with or without apical involvement; the
egional wall motion abnormalities extend beyond a single epi-
ardial vascular distribution; a stressful trigger is often, but not
lways present; (2) absence of obstructive CAD or angiographic
vidence of acute plaque rupture; (3) new electrocardiographic
bnormalities (either ST-segment elevation and/or T wave inver-
ion) or modest elevation in cardiac troponin; and (4) absence
f pheochromocytoma and myocarditis. It is required to estab-
ish worldwide consensus on the diagnostic criteria for tako-tsubo
ardiomyopathy.
linical features
atients’ characteristics
The true prevalence of tako-tsubo cardiomyopathy remains
ncertain because of its under-recognition or absence of worldwide
onsensus on the diagnostic criteria. In addition, some cases of tako-
subo cardiomyopathy may  have been diagnosed as aborted AMI  or
yocarditis in the past. However, according to recent reports from
everal countries including Japan, the USA, and Europe, tako-tsubo
ardiomyopathy probably accounts for 1–3% of patients with sus-
ected AMI  [16,17]. Tako-tsubo cardiomyopathy usually occurs in
ostmenopausal women of an advanced age. Recent reviews of the
ublished case series reveal that approximately 90% of reported
ases have been women and the mean age has ranged from 58
o 75 years [3,6,7,13–19]. The most common symptom is chest
ain or dyspnea which is also frequently found in AMI. Because
hese symptoms in tako-tsubo cardiomyopathy are not usually as
erious as those in AMI, its development may  be diagnosed at a
ater stage or overlooked. Pulmonary edema may  occur, but car-
iac arrest, cardiogenic shock, and serious arrhythmias are rare as
n initial presentation. A unique feature of tako-tsubo cardiomy-
pathy is the occurrence of a preceding emotional or physical
tress. An emotional stress such as an unexpected death of a rela-
ive or friend, domestic abuse, public speaking, or receiving news
f serious diagnosis, and a physical stress such as asthma attack,
astric examination, or non-cardiac operation have been identi-
ed in previous cases [3,6,7,13–23]. These are commonplace events
hat everyone can experience in their daily life. We  experienced 2
ases of tako-tsubo cardiomyopathy that were diagnosed after suc-
essful resuscitation of cardiac arrest [20]. We  recently reportedlowed barium was  seen in the gastrointestinal tract.
Adapted from Ref. [23], with permission.
gender differences in the clinical characteristics [21]. In 10 of the
13 male patients, tako-tsubo cardiomyopathy occurred during or
immediately after receiving medical examination or treatment.
The incidence of in-hospital onset was signiﬁcantly higher in male
patients than in female patients (77% vs 17%, p < 0.01). Our results
suggested that physical stress might be much more associated with
the occurrence in male patients compared to female patients. Physi-
cians should recognize that this disorder can occur unexpectedly
during medical examination or treatment (iatrogenic tako-tsubo
cardiomyopathy) [22,23] (Fig. 4).
Electrocardiogram and cardiac biomarkers
The most common abnormality on the initial ECG is ST-segment
elevation or negative T wave. There is a signiﬁcant variability in
the frequency of these ECG abnormalities in the published reports
possibly because of the variability in time from onset to recor-
ding ECG [3,6,7,13–19]. Typically, ST-segment elevation is found
in precordial leads immediately after the onset. It may  be seen
in limb leads. Because ECG features are similar between tako-
tsubo cardiomyopathy and anterior AMI, several studies have
assessed ECG differences [19,24,25].  Ogura et al. reported that the
absence of reciprocal changes, the absence of abnormal Q wave,
and the sum of ST-segment elevation in leads V4–6 more than the
432 S. Kurisu, Y. Kihara / Journal of Cardiology 60 (2012) 429–437
Fig. 5. Simultaneous tracings of left ventricular and central aortic pressures. Initial recording showed a peak systolic gradient of 60 mmHg. On the ﬁrst sinus beat after a
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dremature ventricular contraction, the peak systolic gradient increased to 130 mmH
dapted from Ref. [31], with permission.
um of ST-segment elevation in leads V1–3 identiﬁed tako-tsubo
ardiomyopathy with a high sensitivity and speciﬁcity [19]. Kosuge
t al. recently reported that the combination of the presence of ST-
egment depression in lead aVR and the absence of ST-segment
levation in lead V1 also showed a high sensitivity and speciﬁcity
or diagnosing tako-tsubo cardiomyopathy [24]. We  reported typ-
cal time course of ECG in tako-tsubo cardiomyopathy as follows
25]. ECG shortly after the onset usually showed ST-segment ele-
ation. Negative T wave deepened progressively to its ﬁrst negative
eak, which occurred at approximately 3 days. The negative T wave
as shallow for several days and then deepened again, the second
egative peak occurring at approximately 2 weeks. QT interval was
rolonged as the T wave deepened, and shortened as the T wave
ecame shallow. Interestingly, the time course of ECG in tako-tsubo
ardiomyopathy mimicked that in reperfused AMI  with minimal
nzymatic release.
Serum levels of creatine kinase, creatine kinase-MB, and
roponin may  be normal or slightly elevated. These levels may
e unexpectedly normal in spite of broad wall motion abnor-
alities during the early stage. Brain natriuretic peptide (BNP)
r N-terminal pro-BNP, a marker of ventricular dysfunction,
s usually elevated, but is not associated with a poor
rognosis [26].
ardiac catheterization
Typically, left ventriculography shows akinesis in the apical and
id  portions of the left ventricular chamber extending beyond one
oronary artery region, with hyperkinesis in the basal portion. The
ize of akinetic area varies during the early stage [27]. It remains
nclear what regulates the size of akinetic area. Left ventricular
all motion abnormalities improve from basal-side to apical-side
28], and are usually resolved during a period of days to weeks.
e experienced a case of tako-tsubo cardiomyopathy in which
eft ventricular apical wall motion abnormalities were resolved
uring only 41 h on left ventriculography [29]. Left ventricular
utﬂow tract obstruction or mitral regurgitation may  be found
uring the early stage [30–32].  In patients with left ventricular out-
ow tract obstruction (obstructive tako-tsubo cardiomyopathy),
rockenbrough–Braunwald–Morrow phenomenon, which is well
nown in hypertrophic obstructive cardiomyopathy, is observed
30,31] (Fig. 5). Acute mitral regurgitation in tako-tsubo car-
iomyopathy is likely due to complex and multiple mechanisms.Nevertheless, the main factor seems to lie in the altered spatial
relationship between mitral leaﬂets and the subvalvular appara-
tus, caused by the apical ballooning. In patients with severe mitral
regurgitation, the shape of left ventriculogram and the resulting
left atriogram during systole resembles a dumbbell (Fig. 6). Apical
wall motion abnormalities or intraventricular obstruction may be
also found in the right ventricle [33]. Recently, apical sparing vari-
ant of tako-tsubo cardiomyopathy has been described, occurring
in a signiﬁcant minority of patients with a clinical presentation
similar to that of typical tako-tsubo cardiomyopathy [34]. Apical
sparing variant of tako-tsubo cardiomyopathy shows limited ECG
abnormalities compared to typical tako-tsubo cardiomyopathy [35]
(Fig. 7). It may  be difﬁcult to obtain early and precise diagnosis of
apical sparing variant of tako-tsubo cardiomyopathy by using ECG.
Most patients with tako-tsubo cardiomyopathy have angio-
graphically normal coronary arteries or mild atherosclerosis. It is
an important concept of this disorder that left ventricular apical
wall motion abnormalities are not due to myocardial ischemia
with coronary atherosclerosis or acute plaque rupture. However,
it is probable that patients with tako-tsubo cardiomyopathy have
an incidental CAD because most patients are elderly. We  recently
reported that incidental CAD (>75% stenosis of a major epicardial
coronary artery) was  found in 10% of patients with tako-tsubo
cardiomyopathy [36]. In patients with CAD in the left anterior
descending artery, it should be carefully judged whether the
CAD is associated with left ventricular wall motion abnormali-
ties to avoid performing unnecessary coronary intervention. We
and another group have also reported that coronary blood ﬂow is
impaired in all coronary arteries, in agreement with akinetic area
extending beyond one coronary artery region by using thromboly-
sis in myocardial infarction (TIMI) frame count [16,37].
Cardiac imaging
Myocardial single-photon emission computed tomography has
shown myocardial perfusion, fatty acid metabolism, and sympa-
thetic function in tako-tsubo cardiomyopathy [13,37,38].  Reduced
uptake of technetium-99m or thallium-201 indicating decreased
myocardial perfusion is found during early stage. Reduced uptake of
iodine-123-beta-methyl-p-iodophenyl pentadecanoic acid, or 123I-
meta-iodobenzylguanidine is also found during the early stage.
These indicate abnormal fatty acid metabolism and sympathetic
denervation, respectively. The regional distribution of abnormal
S. Kurisu, Y. Kihara / Journal of Cardiology 60 (2012) 429–437 433
Fig. 6. Tako-tsubo cardiomyopathy complicated by severe mitral regurgitation. The shape of left ventriculogram and the resulting left atriogram during systole resembles a
d
f
w
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Aumbbell. LA, left atrium; LV, left ventricle.
atty acid metabolism or sympathetic denervation corresponds
ith the regional distribution of left ventricular apical wall motion
bnormalities. Abnormal fatty acid metabolism and sympathetic
enervation are usually sustained even after the resolution of left
entricular wall motion abnormalities. Cardiac magnetic resonance
Fig. 7. Left ventriculogram and electrocardiogram in typical tako-tsubo c
dapted from Ref. [35], with permission.imaging has shown that late gadolinium enhancement is almost
never found, but T2-weighed sequence reveals frequent high sig-
nal intensity suggesting myocardial edema. This modality seems to
be useful in detecting apical thrombus or right ventricular involve-
ment [39].
ardiomyopathy (left panel) and apical sparing variant (right panel).
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Fig. 8. Serial electrocardiogram (left panel) and telemetry monitoring (right panel) in a case of tako-tsubo cardiomyopathy complicated by cardiac rupture. Note that
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dapted from Ref. [42], with permission.
rognosis, complications, and management
Typically, left ventricular apical wall motion abnormali-
ies are transient and resolved during a period of days to
eeks. The prognosis is generally favorable; reported in-hospital
ortality rates range from 0% to 8% [3,6,7,13–19]. Tako-tsubo
ardiomyopathy can occur in critically ill patients during hos-
italization, and their outcome seems to be dependent on the
nderlying disease rather than tako-tsubo cardiomyopathy itself
21]. Recurrence occurs in approximately in 10% of patients [40].
nterestingly, several reports have shown that typical tako-tsubo
ardiomyopathy and apical sparing variant can occur sequen-
ially in the same patient [41]. Tako-tsubo cardiomyopathy can
ccur despite treatment with calcium channel blockers, nitrates, or
eta-blockers, suggesting limitation of these medications to pre-
ent tako-tsubo cardiomyopathy [29]. It is necessary to clarify
he underlying pathophysiological mechanisms and reach con-
ensus in long-term management especially in recurrent cases.
everal acute complications have been reported and highlight the
mplications of tako-tsubo cardiomyopathy. Congestive heart fail-
re has been reported in 3–46% of patients [3,6,7,13–19], and
ome patients require treatment with intraaortic balloon pumping
IABP). Left ventricular free wall rupture or septal perforation is
 rare but fatal complication. Although it is difﬁcult to predict
ubsequent occurrence of this complication immediately after the
nset, several reports have suggested that persistent ST-segment
levation may  be associated with cardiac rupture [42] (Fig. 8). It
hould be investigated whether early and long-term use of IABPor beta-blockers is appropriate for the prevention of cardiac rup-
ture in patients with persistent ST-segment elevation. Hypotension
occurs frequently, and it is important to identify its cause to deter-
mine appropriate management. Acute pump failure may  require
intravenous pressor support or mechanical support with IABP.
However, in some cases, intravenous inotropic agents or IABP cause
left ventricular outﬂow tract obstruction through the inotropic
action and the reduction of afterload, respectively [43]. Bedside
echocardiography can rule out this situation during these sup-
ports. Hypotension may  also occur due to dynamic left ventricular
outﬂow tract obstruction associated with the basal hypercontrac-
tility and systolic anterior movement of the mitral valve anterior
leaﬂet. In this situation, intravenous inotropic agents would be con-
traindicated. In the absence of heart failure, intravenous ﬂuids and
beta-blockers may help by reducing the basal hypercontractility
and increase cardiac ﬁlling, thereby reducing the obstruction [44].
Phenylephrine may  be also effective by increasing the afterload and
left ventricular cavity size in patients who  are intolerant of intra-
venous ﬂuids and beta-blockers. Left ventricular apical thrombosis
may  occur during the early stage due to transient apical aneurysm
formation [45] (Fig. 9). In our experience, it occurred in 5.3% of
patients. There are 2 types of apical thrombus; mural thrombus
and protruding thrombus. Once apical thrombosis develops, an
embolic event is likely to occur because the early improvement
in left ventricular apical contraction may  promote the discharge of
apical thrombus. From this point of view, appropriate anticoagu-
lant therapy should be performed to prevent left ventricular apical
thrombosis until left ventricular apical wall motion abnormalities
S. Kurisu, Y. Kihara / Journal of Cardiology 60 (2012) 429–437 435
Fig. 9. Tako-tsubo cardiomyopathy complicated by left ventricular apical thrombosis. There are 2 types of apical thrombus: mural thrombus (left panel, arrow) and protruding
thrombus (right panel, arrow).
Adapted from Ref. [45], with permission.
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tmprove. Life-threatening, ventricular arrhythmias have been
eported. As mentioned above, QT interval changes dynamically
uring the early stage. Other factors such as hypokalemia, bradycar-
ia, or antiarrhythmic drugs may  further increase the QT interval,
nd lead to Torsade de Pointes. We  experienced 2 cases of Torsade
e Pointes associated with bradycardia [46] (Fig. 10). Tempo-
ary ventricular pacing at a high rate decreased the QT interval
nd prevented the recurrence of Torsade de Pointes. In this sit-
ation, it is also important to correct other factors causing QT
nterval prolongation. Left ventricular wall motion abnormalities
re usually resolved during a period of days to weeks. How-
ver, some patients have persistent left ventricular wall motion
bnormalities although the precise reason remains unclear [22].
n this situation, beta-blockers, angiotensin-converting enzyme
nhibitors, or angiotensin II type 1 receptor blockers are empirically
ecommended.
athophysiology
Several possible mechanisms have been proposed to explain
ako-tsubo cardiomyopathy, but its pathophysiology is not well
nderstood. Early Japanese reports including ours have suggested
hat tako-tsubo cardiomyopathy might result from prolonged
schemia due to multivessel epicardial coronary artery spasm
1–4]. ST-segment elevation is commonly found during the early
tage even when coronary angiography shows no coronary spasm.
lso, spontaneous spasm is infrequent. Because of these clinical
esults, multivessel coronary artery spasm is not strongly sup-
orted as a cause of tako-tsubo cardiomyopathy. We  and some
ther groups have suggested coronary microvascular dysfunction
s a cause of tako-tsubo cardiomyopathy [3,13,17,36,47,48].  We
valuated coronary angiograms in 28 patients with tako-tsubo car-
iomyopathy, and found that TIMI frame count was signiﬁcantly
igher in all coronary arteries of patients with tako-tsubo car-
iomyopathy [36]. Researchers at Mayo Clinic also found abnormal
IMI myocardial perfusion grade in 69% of patients with tako-
subo cardiomyopathy [47]. Consistent results are reported onDoppler guidewire recording. Kume et al. reported decreased coro-
nary ﬂow velocity reserve as well as short diastolic deceleration
in all coronary arteries of 8 patients with tako-tsubo cardiomy-
opathy [48]. In addition, Ito et al. reported that intracoronary
injection of nicorandil acutely reduced the extent of ST-segment
elevation, further suggesting coronary microvascular dysfunction
during early stage [13]. On the other hand, although based on
few patients, Abe et al. reported that no signiﬁcant abnormality
was found on Doppler guidewire or contrast echocardiography
[49]. It is necessary to clarify whether coronary microvascular
dysfunction is the primary cause or only a consequence of tako-
tsubo cardiomyopathy. We  and some groups have reported that
myocardial biopsy reveals unspeciﬁc pathological ﬁndings such as
adipose tissue, slight interstitial ﬁbrosis, mildly atrophic myocar-
dial ﬁbers, and small numbers of mononuclear cells [3,18,49].
Myocarditis is unlikely to be a cause of tako-tsubo cardiomy-
opathy in the view of unspeciﬁc ﬁndings on myocardial biopsy
and negative results on serum tests for viral serology. Further-
more, cardiac magnetic resonance imaging does not show regional
delayed gadolinium hyperenhancement which is a feature of
myocarditis [38]. Catecholamines may  play a role in triggering
tako-tsubo cardiomyopathy because patients often have preced-
ing emotional or physical stress. Wittstein et al. reported high
levels of catecholamines and their metabolites at the time of
presentation, which remained elevated for 7–9 days [18]. On the
other hand, we  and some groups reported inconsistent results that
circulating catecholamines were normal or not very high even
immediately after the onset [3,28,50]. Lyon et al. recently have
proposed that 1 (positive inotropic effects with norepinephrine)
and 2 (negative inotropic effects with high levels of circulat-
ing epinephrine) adrenergic receptors are unevenly distributed
through the myocardium [51]. A relative abundance of 2 recep-
tors in the apical myocardium could explain the tendency for
apical suppression with basal sparing during increased levels of
circulating epinephrine. Further studies are necessary to clar-
ify the underlying pathophysiological mechanisms of tako-tsubo
cardiomyopathy.
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Fig. 10. Tako-tsubo cardiomyopathy complicated by Torsade de Pointes associated with bradycardia. Note the signiﬁcant QT interval prolongation immediately after the
onset.
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onclusions
Tako-tsubo cardiomyopathy is an important disorder as a
ifferential diagnosis of AMI. Precise diagnosis of tako-tsubo car-
iomyopathy has important implications for clinical management
specially during the early stage. Since Dr Sato ﬁrst proposed the
oncept of tako-tsubo cardiomyopathy, more than 20 years have
assed. However, its pathophysiology remains to be investigated.
urther studies are necessary to clarify the underlying pathophysi-
logical mechanisms and reach consensus in acute and long-term
anagement.
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